
Helical tomotherapy and systemic targeted therapies in solitary plasmacytoma: Pilot study
Author(s) -
N. Wiazzane,
Cyrus Chargari,
Corine Plancher,
Jérôme Tamburini,
Bernard Asselain,
A. Fourquet,
Didier Bouscary,
Youlia Kirova
Publication year - 2013
Publication title -
world journal of radiology
Language(s) - English
Resource type - Journals
ISSN - 1949-8470
DOI - 10.4329/wjr.v5.i6.248
Subject(s) - medicine , common terminology criteria for adverse events , tomotherapy , dexamethasone , toxicity , adverse effect , concomitant , magnetic resonance imaging , radiology , nuclear medicine , radiation therapy
To assess the feasibility of the combination of helical tomotherapy(®) (HT) and a concurrent systemic targeted therapy in patients with solitary plasmacytoma (SP) with the aim to decrease toxicity while improving therapeutic efficacy.